{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:44:25Z","timestamp":1790286265192,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1124\/mol.118.115295","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T18:34:05Z","timestamp":1558722845000},"page":"180-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1)"],"prefix":"10.1016","volume":"96","author":[{"given":"Biebele","family":"Abel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip K.","family":"Tosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart R.","family":"Durell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrooz","family":"Vahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh V.","family":"Ambudkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.118.115295_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.aav7102","article-title":"Structural insight into substrate and inhibitor discrimination by human P-glycoprotein","volume":"363","author":"Alam","year":"2019","journal-title":"Science"},{"key":"10.1124\/mol.118.115295_bib2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0076-6879(98)92039-0","article-title":"Drug-stimulatable ATPase activity in crude membranes of human MDR1-transfected mammalian cells","volume":"292","author":"Ambudkar","year":"1998","journal-title":"Methods Enzymol"},{"key":"10.1124\/mol.118.115295_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharmacological aspects of the multidrug transporter","volume":"39","author":"Ambudkar","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.118.115295_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bcp.2015.12.007","article-title":"Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein","volume":"101","author":"Chufan","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.118.115295_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082463","article-title":"Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1)","volume":"8","author":"Chufan","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/mol.118.115295_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1468-3083.2011.04078.x","article-title":"Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial","volume":"26","author":"David","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1124\/mol.118.115295_bib7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1124\/mol.113.088526","article-title":"Pore-exposed tyrosine residues of P-glycoprotein are important hydrogen-bonding partners for drugs","volume":"85","author":"D\u00f6nmez Cakil","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.115295_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.bi.62.070193.002125","article-title":"Biochemistry of multidrug resistance mediated by the multidrug transporter","volume":"62","author":"Gottesman","year":"1993","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/mol.118.115295_bib9","doi-asserted-by":"crossref","first-page":"32622","DOI":"10.1074\/jbc.M113.498980","article-title":"Mutations in intracellular loops 1 and 3 lead to misfolding of human P-glycoprotein (ABCB1) that can be rescued by cyclosporine A, which reduces its association with chaperone Hsp70","volume":"288","author":"Kapoor","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.118.115295_bib10","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1074\/jbc.M010044200","article-title":"Correlation between steady-state ATP hydrolysis and vanadate-induced ADP trapping in Human P-glycoprotein. Evidence for ADP release as the rate-limiting step in the catalytic cycle and its modulation by substrates","volume":"276","author":"Kerr","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.118.115295_bib11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","article-title":"Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense","volume":"204","author":"Leslie","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/mol.118.115295_bib12","doi-asserted-by":"crossref","first-page":"18132","DOI":"10.1074\/jbc.M210413200","article-title":"Allosteric modulation of human P-glycoprotein: inhibition of transport by preventing substrate translocation and dissociation","volume":"278","author":"Maki","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.118.115295_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bcp.2016.10.002","article-title":"Location of contact residues in pharmacologically distinct drug binding sites on P-glycoprotein","volume":"123","author":"Mittra","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.118.115295_bib14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1021\/acs.jmedchem.7b01340","article-title":"Comprehensive synthesis of amino acid-derived thiazole peptidomimetic analogues to understand the enigmatic drug\/substrate-binding site of P-glycoprotein","volume":"61","author":"Patel","year":"2018","journal-title":"J Med Chem"},{"key":"10.1124\/mol.118.115295_bib15","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1021\/bi973045u","article-title":"Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state","volume":"37","author":"Ramachandra","year":"1998","journal-title":"Biochemistry"},{"key":"10.1124\/mol.118.115295_bib16","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1073\/pnas.97.6.2515","article-title":"Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein","volume":"97","author":"Sauna","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.118.115295_bib17","doi-asserted-by":"crossref","first-page":"26501","DOI":"10.1074\/jbc.M601917200","article-title":"Exploiting reaction intermediates of the ATPase reaction to elucidate the mechanism of transport by P-glycoprotein (ABCB1)","volume":"281","author":"Sauna","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.118.115295_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/dmd.111.042721","article-title":"Use of baculovirus BacMam vectors for expression of ABC drug transporters in mammalian cells","volume":"40","author":"Shukla","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.118.115295_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1634\/theoncologist.2012-0211","article-title":"CF102 for the treatment of hepatocellular carcinoma: a phase I\/II, open-label, dose-escalation study","volume":"18","author":"Stemmer","year":"2013","journal-title":"Oncologist"},{"key":"10.1124\/mol.118.115295_bib20","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1021\/acs.jmedchem.5b01998","article-title":"Purine (N)-methanocarba nucleoside derivatives lacking an exocyclic amine as selective A3 adenosine receptor agonists","volume":"59","author":"Tosh","year":"2016","journal-title":"J Med Chem"},{"key":"10.1124\/mol.118.115295_bib21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1021\/acsmedchemlett.5b00150","article-title":"Rigidified A3 adenosine receptor agonists: 1-deazaadenine modification maintains high in vivo efficacy","volume":"6","author":"Tosh","year":"2015","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/mol.118.115295_bib22","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1021\/jm300396n","article-title":"Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions","volume":"55","author":"Tosh","year":"2012","journal-title":"J Med Chem"},{"key":"10.1124\/mol.118.115295_bib23","doi-asserted-by":"crossref","first-page":"9901","DOI":"10.1021\/jm501021n","article-title":"In vivo phenotypic screening for treating chronic neuropathic pain: modification of C2-arylethynyl group of conformationally constrained A3 adenosine receptor agonists","volume":"57","author":"Tosh","year":"2014","journal-title":"J Med Chem"},{"key":"10.1124\/mol.118.115295_bib24","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1021\/acs.jmedchem.7b00141","article-title":"Scaffold repurposing of nucleosides (adenosine receptor agonists): enhanced activity at the human dopamine and norepinephrine sodium symporters","volume":"60","author":"Tosh","year":"2017","journal-title":"J Med Chem"},{"key":"10.1124\/mol.118.115295_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11302-015-9459-2","article-title":"Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain","volume":"11","author":"Tosh","year":"2015","journal-title":"Purinergic Signal"},{"key":"10.1124\/mol.118.115295_bib26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1039\/C4MD00571F","article-title":"Structure-based design, synthesis by click chemistry and in vivo activity of highly selective A3 adenosine receptor agonists","volume":"6","author":"Tosh","year":"2015","journal-title":"MedChemComm"},{"key":"10.1124\/mol.118.115295_bib27","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1016\/j.bmcl.2014.06.006","article-title":"Extended N(6) substitution of rigid C2-arylethynyl nucleosides for exploring the role of extracellular loops in ligand recognition at the A3 adenosine receptor","volume":"24","author":"Tosh","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.118.115295_bib28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1021\/ml300107e","article-title":"Truncated nucleosides as A(3) adenosine receptor ligands: combined 2-arylethynyl and bicyclohexane substitutions","volume":"3","author":"Tosh","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/mol.118.115295_bib29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1124\/mol.118.115295_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcp.2017.07.014","article-title":"Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency","volume":"143","author":"Vahedi","year":"2017","journal-title":"Biochem Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24008940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24008940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.118.115295","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:29:01Z","timestamp":1739960941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24008940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0026895X24008940"],"URL":"https:\/\/doi.org\/10.1124\/mol.118.115295","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1)","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.118.115295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}